Journal of Clinical Pathways July 7, 2020
In January 2018, Elsevier—an information analytics business specializing in science and health—acquired Via Oncology – a leading decision-support and clinical pathways vendor. Since that time, Elsevier has rebranded Via Oncology as ClinicalPath and integrated this solution into the company’s Clinical Solutions portfolio. ClinicalPath delivers evidence-based oncology pathways that are embedded in the provider’s clinical workflow.
Journal of Clinical Pathways sat down with members of the ClinicalPath team for an update on their current activities and vision for pathways. The resulting article addresses how pathways support institutions in reducing unwarranted variation; supporting the clinical workflow and care coordination; managing practice trends; and adapting to changing practice drivers.
Sonali Fonseca, PhD, Vice President of Oncology Pathways and Programs; Tate Erlinger, MD, MPH,...
Today's Sponsors
Today's Sponsor